Could a common cholesterol drug slow a rare liver disease?
Disease control
Ongoing
This study tests whether taking simvastatin daily for 5 years can improve survival and reduce serious complications like liver failure, cancer, or bleeding in people with primary sclerosing cholangitis (PSC). About 560 adults with PSC will receive either simvastatin or a placebo.…
Phase: PHASE3 • Sponsor: Annika Bergquist • Aim: Disease control
Last updated May 11, 2026 20:39 UTC